Los puntos clave no están disponibles para este artículo en este momento.
Metabolic disorders are associated with the progression of chronic kidney diseases. Interfering with fibroblast metabolism may be a promising therapeutic strategy for renal fibrosis and other fibrosis-related diseases.
Wang et al. (Sat,) studied this question.